KMID : 0371420160900030147
|
|
Annals of Surgical Treatment and Research 2016 Volume.90 No. 3 p.147 ~ p.156
|
|
Intraoperative radiofrequency ablation for hepatocellular carcinoma in 112 patients with cirrhosis: a surgeon's view
|
|
Lee Jung-Yeon
Kim Young-Hoon Roh Young-Hoon Roh Kyung-Bin Kim Kwan-Woo Kang Sung-Hwa Baek Yang-Hyun Lee Sung-Wook Han Sang-Young Kwon Hee-Jin Cho Jin-Han
|
|
Abstract
|
|
|
Purpose: This retrospective study was an investigation of overall survival (OS), disease-free survival (DFS) and prognostic factors affecting OS and DFS in cirrhotic patients who received intraoperative radiofrequency ablation (IORFA).
Methods: Between April 2009 and November 2013, 112 patients (94 men, 84%; 18 women, 16%) underwent IORFA for 185 cases of hepatocellular carcinomas (HCC). Repeat IORFA was done in 9 patients during the same period (total of 121 treatments).
Results: All patients were followed-up for at least 12 months (mean follow-up, 32 months). Surgical resection combined with IORFA was performed in 20 patients. The technical effectiveness at 1 week was 91.78% (111 of 121). Readmission was 9.1% (11 of 121) and the most common cause was ventral hernia. Procedure-related mortality was 2.7% (3 of 112) and continued fatal biliary leakage was 1.8% (2 of 112). Local recurrence developed in 10 patients (8.9%). Most recurrence was intrahepatic. Cumulative survival was assessed in 33 patients who received IORFA as primary treatment (naive patients) and 79 non-naive patients. The cumulative DFS and OS rate at l and 3 years was 54% and 24%, and 87% and 66%, respectively. Moderate ascites (P = 0.001), tumor located segment I (P = 0.001), portal vein thrombosis (P = 0.001) had poor survival were significant factors by multivariate analysis.
Conclusion: IORFA alone or in combination with surgical resection extends the spectrum of liver surgery. A fundamental understanding of RFA, additional comorbidities, and postablation complication are necessary to maximize the safety and efficacy of IORFA for treating HCC with cirrhosis.
|
|
KEYWORD
|
|
Hepatocellular carcinoma, Intraoperative, Radiofrequency ablation
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|